Q32 Bio Inc (QTTB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -98,903 | -70,671 | -35,331 | -103,916 | -79,749 |
| Depreciation Amortization | 5,909 | 3,899 | 1,907 | 6,318 | 4,599 |
| Accounts payable and accrued liabilities | 486 | 4,920 | 4,841 | -4,452 | 1,511 |
| Other Working Capital | 103 | 6,346 | 4,649 | 463 | 6,527 |
| Other Operating Activity | 9,685 | 1,673 | -1,912 | 10,229 | 2,087 |
| Operating Cash Flow | $-82,720 | $-53,833 | $-25,846 | $-91,358 | $-65,025 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 208,629 | 169,628 | 117,030 | -29,966 | -13,664 |
| PPE Investments | -2,778 | -2,621 | -2,033 | -21,833 | -18,108 |
| Investing Cash Flow | $205,851 | $167,007 | $114,997 | $-51,799 | $-31,772 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 1,098 | 688 | 672 | 158,213 | 135,638 |
| Other Financing Activity | 0 | 0 | -225 | 0 | 0 |
| Financing Cash Flow | $1,098 | $688 | $447 | $158,213 | $135,638 |
| Beginning Cash Position | 55,048 | 55,048 | 55,048 | 39,992 | 39,992 |
| End Cash Position | 179,277 | 168,910 | 144,646 | 55,048 | 78,833 |
| Net Cash Flow | $124,229 | $113,862 | $89,598 | $15,056 | $38,841 |
| Free Cash Flow | |||||
| Operating Cash Flow | -82,720 | -53,833 | -25,846 | -91,358 | -65,025 |
| Capital Expenditure | -2,778 | -2,621 | -2,033 | -21,833 | -18,108 |
| Free Cash Flow | -85,498 | -56,454 | -27,879 | -113,191 | -83,133 |